Spain Archives - Page 6 of 6

Belgium France Germany Ireland Israel Italy Netherlands Portugal South Africa Spain Sweden Switzerland UK USAAutism Innovative Medicine Studies 2 Trials

July 19, 2022by pcdata

Dates: 01/06/2018 31/05/2023 Topic: Biomarkers identification Procedures Project type: Preclinic Clinic Project target: Neurology Financing: H2020-EU.3.1. – SOCIETAL CHALLENGES – Health; demographic change and well-being MAIN PROGRAMME H2020-EU.3.1.7. – Innovative Medicines Initiative 2 (IMI2) Other Participating agents: KING’S COLLEGE LONDON Keywords: Autism Spectrum Disorder; clinical trial; biomarker; procedures; network; consortium Countries: UK; Switzerland; Netherlands; Spain;...

SpainGenomic Data-Fusion Platform for Omics-Driven Precision Medicine

July 19, 2022by pcdata

Dates: 01/09/2020 31/08/2023 Topic: AI/Big data Project type: Preclinic Project target: Other Financing: H2020-EU.1.1. – EXCELLENT SCIENCE – European Research Council (ERC) Participating agents: BARCELONA SUPERCOMPUTING CENTER-CENTRO NACIONAL DE SUPERCOMPUTACION Keywords: big data; genome; OMICs; NMTF; non-negative matrix tri-factorization; platform; AI Countries: Spain Project page: Access page

France Greece Netherlands Spain Switzerland USAHost-targeted Approaches for the Prevention and the treatment of Hospital-Acquired Pneumonia

July 19, 2022by pcdata

Dates: 01/01/2020 31/12/2024 Topic: Biomarkers identification Strategies Project type: Preclinic Clinic Project target: Infectious disease Financing: H2020-EU.3.1. – SOCIETAL CHALLENGES – Health; demographic change and well-being H2020-EU.3.1.3. – Treating and managing disease Participating agents: CENTRE HOSPITALIER UNIVERSITAIRE DE NANTES Keywords: hospital-acquired pneumonia; pneumonology; antibiotic; infectious disease; drug resistance; biomarker; strategy; OMICs; clinical trial; procedure Countries:...

Denmark France Netherlands Spain UKElectrochemically-enabled high-throughput peptidomics for next-generation precision medicine

July 19, 2022by pcdata

Dates: 01/01/2020 31/12/2023 Topic: Tool AI/Big Data Project type: Preclinic Theranostic Immunotherapy Project target: Cancer Vaccines Financing: H2020-EU.1.2. – EXCELLENT SCIENCE – Future and Emerging Technologies (FET) H2020-EU.1.2.1. – FET Open Participating agents: LUXEMBOURG INSTITUTE OF SCIENCE AND TECHNOLOGY -UNIVERSITEIT TWENTE -UNIVERSITY OF GLASGOW -UNIVERSIDAD POMPEU FABRA -KOBENHAVNS UNIVERSITET -ELVESYS Keywords: precision medicine; screening proteins;...

Belgium France Germany Luxembourg Netherlands Slovenia Spain UKTranslational SYStemics: Personalised Medicine at the Interface of Translational Research and Systems Medicine

July 19, 2022by pcdata

Dates: 01/09/2019 31/08/2023 Topic: Training Project type: Preclinic Project target: Other Financing: H2020-EU.1.3. – EXCELLENT SCIENCE – Marie Sk?odowska-Curie Actions H2020-EU.1.3.1. – Fostering new skills by means of excellent initial training of researchers Participating agents: KATHOLIEKE UNIVERSITEIT LEUVEN Keywords: big data; data processing; systemic medicine; translational research; training Countries: Belgium; Netherlands; Spain; Slovenia; Luxembourg; France;...

SpainIMIBIC Fellowship Programme for Personalised and Precision Medicine

July 19, 2022by pcdata

Dates: 01/08/2019 31/07/2025 Topic: Training Project type: Preclinic Project target: Other Financing: H2020-EU.1.3. – EXCELLENT SCIENCE – Marie Sk?odowska-Curie H2020-EU.1.3.4. – Increasing structural impact by co-funding activities Other Participating agents: FUNDACION PARA LA INVESTIGACION BIOMEDICA DE CORDOBA Keywords: big data; fellowship; training; biomedical; ICT Countries: Spain Project page: Access page

Australia Austria Belgium France Germany Italy Netherlands Slovenia Spain Switzerland USAindividualizedPaediatricCure: Cloud-based virtual-patient models for precision paediatric oncology

July 19, 2022by pcdata

Dates: 01/01/2019 31/05/2023 Topic: Tool AI/Big Data Project type: Preclinic Theranostic Project target: Cancer Financing: H2020-EU.3.1. – SOCIETAL CHALLENGES – Health; demographic change and well-being H2020-EU.3.1.5.3. – Using in-silico medicine for improving disease management and prediction Other Participating agents: TECHNIKON FORSCHUNGS- UND PLANUNGSGESELLSCHAFT MBH Keywords: paediatric; oncology; big data; cancer; machine learning; stadistics; tumour; clinical...

Spain UKICON-BIO Integrated Connectedness for a New Representation of Biology

July 19, 2022by pcdata

Dates: 01/04/2018 30/09/2024 Topic: AI/Big data Project type: Preclinic Theranostic Project target: Cancer Infectious disease Financing: H2020-EU.1.1. – EXCELLENT SCIENCE – European Research Council (ERC) Participating agents: BARCELONA SUPERCOMPUTING CENTER-CENTRO NACIONAL DE SUPERCOMPUTACION UNIVERSITY COLLEGE LONDON Keywords: big data; mathematical model; biomarker; NMTF; non-negative matrix tri-factorization; covid-19; cancer; OMICs; Countries: Spain; UK Project page: Access...

Belgium Germany Italy Netherlands Slovenia Spain UKEuropean network staff eXchange for integrAting precision health in the health Care sysTems

July 19, 2022by pcdata

Dates: 01/03/2019 31/08/2024 Topic: Training Project type: Preclinic Project target: Other Financing: H2020-EU.1.3. – EXCELLENT SCIENCE – Marie Sk?odowska-Curie Actions H2020-EU.1.3.3. – Stimulating innovation by means of cross-fertilisation of knowledge Participating agents: UNIVERSITA CATTOLICA DEL SACRO CUORE Keywords: big data; AI; training; network; education; technology; policy; e-health Countries: Italy; Germany; Netherlands; Slovenia; UK; Belgium; Spain...

Belgium Croatia Denmark France Germany Ireland Italy Netherlands Norway Poland Portugal Spain Sweden Switzerland UKIdentification of the Molecular Mechanisms of non-response to Treatments; Relapses and Remission in Autoimmune; Inflammatory; and Allergic Conditions

July 19, 2022by pcdata

Dates: 01/09/2019 31/08/2026 Topic: Tool AI/Big Data Biomarkers identification Project type: Preclinic Clinic Guidelines Project target: Autoimmune disease Other Financing: H2020-EU.3.1. – SOCIETAL CHALLENGES – Health; demographic change and well-being H2020-EU.3.1.7. – Innovative Medicines Initiative 2 (IMI2) Other Participating agents: FUNDACION PUBLICA ANDALUZA PROGRESO Y SALUD Keywords: systemic lupus erythematosus; rheumatoid arthritis; multiple sclerosis; asthma;...

Newer Posts